Specimen requirement |
Adult patient: EDTA tube Number of vials: 2 Minimum blood volume: 6 mL |
|||||||||||||||||||
Paediatric patient: Paediatric EDTA tube Number of vials: 3 Minimum blood volume: 3.9 mL |
||||||||||||||||||||
Authorisation code required | No | |||||||||||||||||||
24 Hr available service | No | |||||||||||||||||||
Precaution |
Refer to protocol for investigation of primary hyperaldosteronism (renin-aldosterone test) for patient preparations. |
|||||||||||||||||||
Method | Liquid chromatography-tandem mass spectrometry | |||||||||||||||||||
Reference interval |
| |||||||||||||||||||
Clinical indication | Investigation of hypertension when primary hyperaldosteronism or unilateral renal disease is suspected. Assessing adequacy of mineralocorticoid replacement Management of congenital adrenal hyperplasia |
|||||||||||||||||||
Result interpretation |
The plasma aldosterone / renin ratio is of greater diagnostic value than either test alone. A high aldosterone / renin ratio suggests a mineralocorticoid abnormality. Elevation of both aldosterone and renin to a similar extent suggests a renal abnormality. Lateralising studies are done in suspected unilateral renal ischaemia or renal artery stenosis. In congenital adrenal hyperplasia, excessive levels indicate inadequate mineralocorticoid replacement. |
|||||||||||||||||||
Measurement of uncertainty | See table. | |||||||||||||||||||
Frequency of measurement | Biweekly |